Lysozyme Foam Mouthwash OEM: How to Validate Enzyme Activity, Formula Compatibility and Shelf Stability

TAKEAWAYS

• One declared lysozyme amount is not one activity result: a raw-material COA identifies the incoming enzyme; an activity method on the finished matrix shows whether the agreed function is still measurable after formulation and processing.

• A final formula needs its own matrix screen: pH, buffer, ionic conditions, surfactants, flavor-solubilization aids, humectants, preservatives, and air–liquid interfaces can affect a protein differently from water or a supplier’s reference buffer.[1]

• Protein content and enzyme activity are separate release questions: an HPLC or identity result may support amount or integrity, but it should not automatically replace a suitably qualified activity assay.[2]

• The filled foamer pack is part of the test article: retain activity evidence at defined checkpoints using the selected bottle, pump, closure, fill level, and storage plan—not only an early bulk sample.[4]

• Preservation, enzyme retention, and marketing claims require three approvals: a preservation assessment does not prove retained lysozyme activity; neither result authorizes therapeutic or antimicrobial claims in every market.[5][6]

Why Does a Lysozyme Foam Mouthwash Need a Different Approval Logic?

Because the product is a protein-containing water-based system that must also dispense through a foam-generating package. Lysozyme is used in oral-care formats and is naturally present in saliva, but evidence from another formula or delivery format cannot be transferred unchanged to a new foam mouthwash.[3] The relevant buyer question is not “Does lysozyme exist in oral care?” It is “Does this final formula retain the defined activity we agreed to measure?”

The existing foam mouthwash OEM guide covers foam density, pump output, and pack behavior. This page treats foam as part of the enzyme environment. The brief should identify enzyme source/grade, formula revision, addition point, activity method, acceptance rule, and final package revision.

How Should an OEM Define “Retained Lysozyme Activity”?

Define it as a pre-agreed method result for a stated final-product sample—not as a marketing adjective. A useful specification identifies the assay, unit, sample preparation, control, action limit, and conditions for comparability.

A published study used a turbidimetric method based on Micrococcus lysodeikticus lysis and a reverse-phase HPLC assay to monitor formulated lysozyme under its own study conditions.[2] For this project, establish which method attributes support the intended decision in the final formula. Do not treat a content or identity result as a stand-alone activity result unless its equivalence for that use has been demonstrated.

For a foam mouthwash, the written protocol should state whether the laboratory measures the bulk liquid, a dispensed sample, or both. It should document pump state, collection, dilution, test temperature, blank, positive/reference control, and how formula interference is addressed. This page does not prescribe one universal activity value, assay volume, or timepoint; those belong to the approved product specification.

Problem #1: Why Is a Content or COA Result Used as Proof of Enzyme Function?

It should not be. A COA supports incoming-material control; it does not prove the finished formula retained the intended activity. Likewise, a chromatography or protein-content result may be valuable for identity or amount, but it cannot by itself prove functional activity after exposure to the actual formula and process.

Lysozyme formulation research has found that pH, interfaces, and buffer/salt conditions can influence secondary structure and enzymatic activity.[1] A foaming rinse adds an air–liquid interface alongside flavor solubilizers, surfactants, humectants, water, and preservatives. The first activity test should therefore use the whole proposed formula or a justified final-formula equivalent, with a matching placebo control.

OEM sample check: retain the raw-material COA and test a baseline finished-formula sample using the agreed activity method. On the report, record formula revision, enzyme lot, batch date, sample preparation, operator/lab, method version, and result. If the formula changes, do not silently carry the old activity result forward.

Problem #2: Why Are Surfactants, Flavor Systems, and Preservation Assumed Compatible?

They need a deliberate compatibility screen because each excipient system can change the enzyme’s environment or the assay’s readability. The right question is not whether a surfactant is “gentle” in marketing language. It is whether the selected complete system allows the planned activity method to produce interpretable, repeatable results and whether the product remains acceptable through its intended shelf-life study.

Build a small development matrix rather than testing one attractive prototype. Compare the candidate base, the same base plus lysozyme, and relevant flavor/solubilizer or preservative variations. Track activity alongside appearance, odor, pH, foam delivery observation, and phase or pack change. No paper supplies a universal finished-mouthwash recipe.[1]

Do not use lysozyme as a shortcut for preservation. ISO 11930 describes how preservation efficacy or microbiological risk assessment can be used to evaluate overall antimicrobial protection for cosmetic products in scope.[5] That is a separate decision from retained enzyme activity. For the selected target market and product classification, the project should maintain both quality routes where applicable.

Problem #3: Why Is Activity Checked in Bulk but Not in the Filled Foam Pack?

Because an early bulk pass does not establish the activity result for a final packaged SKU. Include the selected bottle, pump, closure, fill condition, and storage plan in the activity-stability study, and retain a documented sample route for the activity method. Where post-dispense testing is included, define collection so that foam collapse, mass/volume, and dilution do not create a misleading comparison.

For ordinary pump-performance methods—priming, output, recovery, leakage, mesh, seals, and foam delivery—use the separate foam mouthwash validation guide. This page adds the activity result to final-pack review rather than duplicating those generic pack tests.

Four Sample Gates Before Mass Production

A four-gate evidence file is more useful than a one-time “enzyme added” statement. The following is a Qiaoerna project framework, not a legal standard or a guarantee that every formula will pass.

A useful approval meeting ends with a written decision: approve, revise, extend the study, or reject. It should also list re-test triggers: a lysozyme supplier or lot-strategy change, formula, flavor-system, preservative, bottle/pump/mesh, addition-order, or target-market/claim change.

Source, Microbiology, and Claims: Why Are They Three Separate Approvals?

Because an enzyme’s source documents, a water-based product’s microbiological control, and public claims answer different questions. Supplier and ingredient documentation must be reviewed for the selected grade and target market. Before artwork is locked, obtain source/grade confirmation, a lot-specific COA, storage instructions, an allergen declaration where relevant, and the documentation required for the intended market. Use the proposed finished formula to decide which variables—including pH, buffer or ionic conditions, surfactant/flavor system, processing exposure, and addition order—need compatibility screening. General online guidance does not replace grade-specific supplier documentation or final-formula results.

For a U.S. route, product classification depends on intended use, including advertising and other claims. FDA states that a cosmetic marketed with drug claims can be subject to different requirements.[6] Set the preliminary intended-use and claim boundary when the project brief is created, then complete market-specific classification, substantiation, and legal review before artwork or launch.

Examples of factual project descriptions, subject to target-market review, include “lysozyme-containing foam mouthwash,” “enzyme activity assessed using a documented method,” and “final formula evaluated for compatibility.” These descriptions do not themselves establish a permitted consumer claim or product classification.

For product-format options, see Qiaoerna’s Mouthwash OEM/ODM solutions. For a project brief covering formula, sample and packaging coordination, start with customized oral-care services.

FAQ: Lysozyme Foam Mouthwash OEM

Can lysozyme be used in a foam mouthwash?

It can be evaluated in a foam mouthwash, but feasibility is not proven by its use in another oral format. The final formula, process, foam-pack system, activity method, target market, and claims route must be reviewed together.

What should a lysozyme raw-material COA show?

Request the supplier/material identity, lot number, declared activity and test method, assay unit, storage condition, specification status, and relevant source documentation. A COA supports incoming-material control; it is not the finished-product activity report.

Is an HPLC result enough to approve a lysozyme foam mouthwash?

No single method is automatically sufficient. An HPLC result may support the attribute it has been shown to measure in the final formula, while an activity method addresses the agreed activity result. Approve the test package only after its suitability for the intended decision and product matrix has been established.

Does a preservative challenge test prove lysozyme activity is retained?

No. A preservation-efficacy or microbiological-risk assessment assesses product antimicrobial protection in its scope. Retained lysozyme activity needs a separate, documented activity method.

Can Qiaoerna customize the foam, flavor, and package as well as the enzyme concept?

A project can start with the intended sensory profile, foam format, formula direction, packaging, and target market. However, every material or package change that could affect the approved matrix should be assessed against the activity-and-stability plan.

What should a brand approve before the first bulk run?

Approve the formula and package revision, enzyme source/lot strategy, written activity method, acceptance criterion, sample collection route, stability plan, documentation list, target-market claim boundary, and change-control triggers.

What are the typical first-step inputs for an OEM sample project?

Provide the target market, desired product positioning, preferred lysozyme source or supplier constraints, alcohol/fluoride preferences, flavor direction, bottle/pump concept, estimated order scope, documentation needs, and the claims the brand hopes to explore. Qiaoerna can then define a sample brief and the evidence required before scale-up.

Plan the evidence before the artwork. Share the target market, enzyme source preference, foam experience, package direction, and claim intent with Qiaoerna so the sampling plan can connect formulation, activity assessment, pack review, and documentation before mass production.

References

1. Malzert A, Boury F, Renard D, Robert P, Proust JE, Benoît JP. Influence of some formulation parameters on lysozyme adsorption and on its stability in solution. International Journal of Pharmaceutics. 2002;242(1–2):405–409. https://doi.org/10.1016/S0378-5173(02)00226-0

2. Liao YH, Brown MB, Martin GP. Turbidimetric and HPLC assays for the determination of formulated lysozyme activity. Journal of Pharmacy and Pharmacology. 2001;53(4):549–554. https://doi.org/10.1211/0022357011775668

3. Ferraboschi P, Ciceri S, Grisenti P. Applications of Lysozyme, an Innate Immune Defense Factor, as an Alternative Antibiotic Agent. Antibiotics. 2021;10(12):1534. https://doi.org/10.3390/antibiotics10121534

4. APACKAGING GROUP. How do you test a foamer pump with a cosmetic formula? https://apackaginggroup.com/blogs/news/how-do-you-test-a-foamer-pump-with-a-cosmetic-formula

5. International Organization for Standardization. ISO 11930:2019 Cosmetics — Microbiology — Evaluation of the antimicrobial protection of a cosmetic product. https://www.iso.org/standard/75058.html

6. U.S. Food and Drug Administration. Is It a Cosmetic, a Drug, or Both? https://www.fda.gov/cosmetics/cosmetics-laws-regulations/it-cosmetic-drug-or-both-or-it-soap